Dr Magnus Nicolson MBA FRSM FRSC

Company: Invizius Limited

Job title: Chief Executive Officer

Seminars:

12:30 PM The Impact of Factor H Related Proteins in the Pathogenesis of IgA Nephritis 12:30 pm

Pioneering Factor H targeted therapies as a vital regulator of the complement system and preventing immune overactivity by controlling protein activation and protecting healthy cells Harnessing important anti-inflammatory and anti-thrombotic properties, contributing to broader physiological balance as a therapeutic methodRead more

day: Conference Day 2

3:30 PM Panel Discussion and Q&A: Navigating Global Partnerships, Funding Strategies & Value Demonstration in the Rare & Genetic Kidney Disease Field

Delving into challenges and best practices for safeguarding intellectual property during global collaboration efforts in the development and commercialization of therapies for renal disease Addressing the reluctance in conducting head-to-head trials Exploring alternative strategies for demonstrating clinical and economic value of novel drug mechanisms compared to existing treatment options Discussing innovative funding models, partnership strategies…Read more

day: Conference Day 2